Alkem Laboratories unveils the brand name of its API business, Alkem Activa

INDIA – Alkem Laboratories is eyeing an international expansion of its active pharmaceutical ingredients (API) business under its own brand name, Alkem Activa.

To Alkem Laboratories, Alkem Activa represents a sharpened focus on the company’s commitment to becoming a formidable global player in the API sector.

Alkem Activa plans to expand its capacity, incorporating cutting-edge technologies like biocatalytic and continuous manufacturing technologies to consolidate its position in the API field.

In a press release, Sandeep Singh, Managing Director of Alkem Laboratories, said: “Alkem Activa represents our renewed commitment to API excellence, innovation, and global outreach.”

Alkem Activa signifies a pivotal move for Alkem Laboratories as the company is dedicated to producing a diverse range of high-quality APIs that cater to the evolving needs of the pharmaceutical industry.

Alkem Activa endeavors to establish strategic partnerships and collaborations in order to position itself as a dependable provider of top-notch Active Pharmaceutical Ingredients (APIs) to pharmaceutical enterprises across the globe.

By collaborating with pharmaceutical companies across the globe, Alkem Activa aims to make a significant contribution to the global healthcare ecosystem.

It represents a renewed sense of purpose to focus on sustainability and ensures that it remains at the forefront of API innovation through responsible practices.

In his address, Sandeep Singh stated: “We aim to strengthen our position in the API market, enhance accessibility to quality pharmaceutical ingredients, and shape the future of healthcare together with our partners.”

By establishing an Alkem Activa brand, Alkem Laboratories is poised to introduce numerous active pharmaceutical ingredients, and equally important, bolster its robust product portfolio.

This news comes shortly after Alkem Laboratories ventured into the Ophthalmology space in India with the launch of an extensive portfolio of affordable and quality eye care products.

It is in harmony with the company’s ongoing endeavors to advance healthcare and provide innovative solutions at affordable rates to patients worldwide.

Similarly, Alkem Laboratories expanded its product portfolio with the launch of its novel antibiotic that is effective against multidrug-resistant bacteria under the brand name Zidavi.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.